You bring the question and the data. We run it through DNAI's research-grade pipeline — multi-omics encoding, physics-constrained simulation, uncertainty quantification — and return a structured report with metrics, artifacts, and explicit limitations. No model access required. No integration work.
Each engagement is scoped, priced, and delivered as a fixed-scope project. No open-ended consulting.
You have a cohort, a biomarker, or a model output you want to stress-test. We encode your data through DNAI's pipeline and quantify discrimination, calibration, and applicability — showing where the signal holds, where it degrades, and where the model abstains.
You have PDX data and want to understand how it maps to human biology. We run your preclinical data through DNAI's Domain Separation Network to disentangle tumor biology from species-specific stroma, then generate human-scale analog trajectories under explicit assumptions — with quantified translation confidence.
Fixed scope. No integration required. You never touch our models.
We define the question, data requirements, and success criteria together. Fixed deliverables, fixed timeline.
You send de-identified data via secure channel. We run automated QC checks and confirm data integrity.
We run the full DNAI pipeline on your data. Gene alignment, VAE encoding, Hypernet simulation, safety checks.
Structured report with metrics, visualizations, and honest limitations. Optional review call to discuss findings.
You get the output of a production-grade pipeline without the cost of building one.
No API integration, no model deployment, no infrastructure. Send data, get results. Weeks, not quarters.
Black-box execution. You receive reports and machine-readable artifacts — not model weights or code. Your data is processed in isolated environments, never used to retrain our base models, and retention terms are defined by contract.
Every report includes what we can and cannot say. Structured abstention, distribution shift diagnostics, and per-cancer reliability tiers.
The same production infrastructure that powers dnai.bio
"We have PDX response data on our compound. Can we explore which human patient subtypes show differential simulated sensitivity?"
"We ran a Phase II. Can we retroactively identify the molecular subgroup that benefited most?"
"We want an independent external validation of our biomarker on DNAI's 9,400-patient reference cohort."
"We have a sarcoma cohort with RNA-seq and outcomes. Can DNAI stratify them by simulated treatment sensitivity?"
"We discovered a biomarker in glioma. Can we test it against DNAI's latent space and external validation cohorts?"
"We want per-patient digital twins with pathway attribution for a grant submission."
Standard deliverables for each engagement type
| Deliverable | Reality Check | Translation Bridge |
|---|---|---|
| Gene alignment + data QC report | ||
| Per-cancer C-index with confidence intervals | ||
| Transportability certificates (GREEN/YELLOW/RED) | ||
| Distribution shift diagnostics | ||
| Per-horizon calibration curves | — | |
| Structured abstention analysis | ||
| DSN alignment + translation confidence | — | |
| Per-pathway fidelity scores | — | |
| Human-scale analog trajectories | — | |
| Biological validity gates | — | |
| Summary report with limitations | ||
| Review call with DNAI team |
The Validation Lab is a standalone engagement with no follow-on obligation. If the evaluation demonstrates fit for your use case, deeper collaboration is an option — not an expectation.
All Validation Lab outputs are intended for research purposes and in silico hypothesis generation. They are not validated for regulatory submissions, clinical decision-making, or patient selection.
Tell us about your data and your question. We'll scope a fixed deliverable and timeline within a week.